Saturday 17 October 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 44.1%, free cash flow grew 141.2% and total debt rose 42.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

121.84 0.33 +0.27%

Follow HALO

Alert me

Market cap: $13.8B
P/E: 34.6×
Fwd P/E: 10.6×
Dividend yield: —
F-score: 5/9
Altman Z: 3.46
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	15.00	25.79	22.13	22.24
P/S ratio Full definition →		6.92	5.77	5.06	5.52
P/FCF ratio Full definition →		11.62	12.51	11.44	11.39
P/Operating CF Full definition →		48.14	36.82	42.40	38.10
P/B ratio Full definition →		17.06	165.22	34.77	63.95
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		7.57	7.72	6.27	6.67
EV/EBITDA Full definition →		11.46	19.20	15.27	15.43
EV/Operating CF Full definition →		15.39	16.54	13.97	13.55
EV/FCF Full definition →		12.72	16.72	14.17	13.76
Quick Ratio Full definition →		1.25	3.30	2.14	1.99
Current Ratio Full definition →		1.59	4.66	2.76	2.71
Net Debt/EBITDA Full definition →		3.37	(31.07)	8.28	5.93
Debt/Assets Full definition →		68.01%	84.85%	80.24%	83.29%
Debt/Equity Full definition →		3.00	43.89	9.76	14.95
Asset Turnover Full definition →		0.57	0.61	0.62	0.72
Operating CF/Net income Full definition →		1.02	(1.55)	1.20	1.05
Capex/Depreciation Full definition →		20.34	(15.78)	(0.10)	(0.12)
Interest Coverage Full definition →		50.73	(18.91)	33.50	51.48
Research and Development Expense of Revenue Full definition →		4.87%	70.12%	6.79%	5.75%
Selling, General and Administrative Expense of Revenue Full definition →		13.01%	17.05%	15.36%	11.85%
Intangible Assets out of Total Assets Full definition →		0.34	0.62	0.57	0.58
Share Based Compensation of Revenue Full definition →		3.43%	3.67%	4.42%	3.68%
Graham Net Nets Full definition →		(0.05)	(0.20)	(0.19)	(0.16)
Graham Number Full definition →		21.75	4.89	11.05	9.85
Earnings Yield Full definition →		6.67%	3.88%	4.52%	4.50%
Free Cash Flow Yield Full definition →		8.60%	7.99%	8.74%	8.78%
Revenue per Share Full definition →		3.02	3.77	3.19	4.10
Operating CF per Share Full definition →		1.52	1.83	1.52	2.05
Capex per Share Full definition →		3.80	(3.76)	(0.03)	(0.04)
Free Cash Flow per Share Full definition →		5.33	(1.93)	1.49	2.02
Cash per Share Full definition →		5.99	1.19	2.70	1.97
Shareholders Equity per Share Full definition →		4.30	0.41	1.86	1.22
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		4.30	0.41	1.86	1.22
Free Cash Flow Full definition →		624.44	(231.27)	176.34	236.72
Working Capital Full definition →		491.52	648.12	639.83	588.59
Capital Expenditures Full definition →		445.84	(450.30)	(3.74)	(4.17)
Net Current Asset Value Full definition →		(388.57)	(1,651.30)	(1,450.05)	(1,500.84)
EV/EBIT Full definition →		12.76	22.98	18.48	18.58
Capex to Sales Full definition →		(1.26)	1.00	0.01	0.01
Price to Operating Income Full definition →		11.66	17.20	14.91	15.37
Other line items
Average Receivables Full definition →		315.89	374.86	381.31	386.08
Average Payables Full definition →		13.88	15.57	17.09	21.15
Average Inventory Full definition →		158.60	159.17	160.17	159.32
Average Assets Full definition →		2,169.63	2,294.40	2,434.63	2,315.65
Average Common Equity Full definition →		478.31	206.32	350.95	238.15

Fold the line items

Columns are period end dates

Stockrow Weekly